Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat.
about
Identification of TGF-beta receptor-1 as a key regulator of carbon nanotube-induced fibrogenesisGalectin-3 regulates myofibroblast activation and hepatic fibrosisAdenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated ratsPharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic FibrosisEfficient hepatic delivery of drugs: novel strategies and their significanceThe stress-regulated transcription factor CHOP promotes hepatic inflammatory gene expression, fibrosis, and oncogenesisModern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targetsThe hepatitis B virus encoded oncoprotein pX amplifies TGF-beta family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosisPlasminogen activators direct reorganization of the liver lobule after acute injuryLack of the matricellular protein SPARC (secreted protein, acidic and rich in cysteine) attenuates liver fibrogenesis in miceSmad2 and Smad3 play different roles in rat hepatic stellate cell function and alpha-smooth muscle actin organizationRNA interference targeting the platelet-derived growth factor receptor beta subunit ameliorates experimental hepatic fibrosis in ratsEffects of c-myb antisense RNA on TGF-beta1 and beta1-I collagen expression in cultured hepatic stellate cellsAcetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cellsEffects of Chinese traditional compound, JinSanE, on expression of TGF-beta1 and TGF-beta1 type II receptor mRNA, Smad3 and Smad7 on experimental hepatic fibrosis in vivo.Construction of prokaryotic expression system of TGF-beta1 epitope gene and identification of recombinant fusion protein immunity.Urokinase-type plasminogen activator supports liver repair independent of its cellular receptorComparison of liver regeneration after a splenectomy and splenic artery ligation in a dimethylnitrosamine-induced cirrhotic rat model.Differential expression of hepatic fibrosis mediators in sick and spontaneously recovered mice with experimental biliary atresiaGene therapy for liver cirrhosis.Anchoring hepatic gene expression with development of fibrosis and neoplasia in a toxicant-induced fish model of liver injuryDevice-based local delivery of siRNA against mammalian target of rapamycin (mTOR) in a murine subcutaneous implant model to inhibit fibrous encapsulation.TGFbeta1 in liver fibrosis: time to change paradigms?Blockade of transforming growth factor-beta1 accelerates lymphatic regeneration during wound repair.Advances in gene therapy of liver cirrhosis: a review.Suppression of CB1 cannabinoid receptor by lentivirus mediated small interfering RNA ameliorates hepatic fibrosis in rats.Preliminary experimental study of urethral reconstruction with tissue engineering and RNA interference techniques.Current concepts in radiation enteritis and implications for future clinical trials.Developing strategies for liver fibrosis treatment.Transforming growth factor-beta1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection.Attenuation of CCl4-induced hepatic fibrosis in mice by vaccinating against TGF-β1Hepatitis C and liver fibrosis.Reduction of bleomycin induced lung fibrosis by transforming growth factor beta soluble receptor in hamsters.TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosisHepatocyte-specific deletion of ARNT (aryl hydrocarbon Receptor Nuclear Translocator) results in altered fibrotic gene expression in the thioacetamide model of liver injury.Gene therapy of liver diseases.Targeted treatments for cirrhosis.Current research of hepatic cirrhosis in China.Expression of exogenous rat collagenase in vitro and in a rat model of liver fibrosis.Enhanced effect of soluble transforming growth factor-beta receptor II and IFN-gamma fusion protein in reversing hepatic fibrosis.
P2860
Q23910071-578BB718-C9DE-4915-9571-3E0E1A3DBB65Q24546358-BF5C0E89-EF7A-4164-B5D9-DEBE0896B2E8Q24792944-2733FE63-8278-4710-85A3-7A505968628DQ26768588-0AB0265A-079D-4400-8B50-C95B44C0D182Q27007518-044802E6-36BE-4FE1-AB24-55BA55772B77Q27319729-E9A2E670-24CF-45D0-87DF-D7E4E5C81C99Q28303698-BDD217FB-4427-4282-8915-4522FC6EE0FBQ28355178-A2531C4E-0550-4AC4-8D31-4AA2B1E20991Q28359705-12AF43FE-70D7-417A-A89D-DB6764E33887Q28486111-CCA447B6-1A6A-47F1-8580-0C6AE1AE24D0Q28567374-4D6AC57A-6973-43EA-9B6D-8C59865A0BE2Q28569125-F7B9F7CA-9E35-41ED-86A9-A168C034BF8BQ28576895-1A41259E-DBAA-4071-83F9-81F5262032F0Q28581233-70BBFBA7-AD28-4863-B6E0-4D1132DC9955Q31158693-E2C7CEA3-066D-4ED8-8E0E-413C2D528A46Q33231853-78C3B6B6-D740-4ED1-B4E4-275E4A7A6FB4Q33264968-F2E9245B-93A9-4E32-A16F-08BCD0199844Q33622777-B88E2846-845A-4DDA-844C-1A25C53C7923Q33749232-7EC94D0C-0767-4C41-841C-C06E4D1CDAF3Q33888055-539ECF30-1A42-4A1C-99E0-10928BB6E64DQ33894802-A4DFDD70-A3C0-4A5E-8695-B41767B6EAB1Q34288026-808424D8-1767-4CF8-BF26-B4E4CFAC3266Q34322705-F31B7B73-D889-4BE9-B6F8-0B3F09A7AFACQ34358339-A8A6D842-4CAE-480C-BBFA-7FA75A373AA6Q34512008-1479C94F-80EB-4DE5-B527-4578265A35EDQ34515920-5BFA4822-1F29-4C6E-8CF2-4B2084F34956Q34642580-51715F1F-EC74-4009-B49E-FC230DF3A79FQ34810813-5691A2EB-9BD3-4FEB-BFF4-CD19056BC1E9Q35001014-DA3F1E0A-B39E-4AAB-A45B-E08719A8DE83Q35010511-EB0380FC-ECA7-485A-90AA-41AEB250C034Q35070050-584BD89D-A155-4E81-979F-B73E8CB02DC2Q35091476-98B07192-724F-428F-B621-0C498EAAC47DQ35533319-5672E549-CD40-4508-A9A2-EE963EA78D82Q35533799-0B7BB27D-FFA7-462B-8D96-2B8EC9ECD572Q35587785-4B5D2478-66CB-4946-B844-05D07309C6E2Q35842662-FA98308D-3DEC-4151-8288-05DCEFAE70D7Q35911123-7BA97B62-5D65-417D-8E07-590934DB1E2AQ36012546-2D44791F-96BD-4E53-9A70-433BE32CD65CQ36309008-BD96254B-909F-4C3E-9166-FAD68D2EC55FQ36326462-F4D599EC-6575-4F51-A416-A35D2158F24A
P2860
Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 1999
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Blockade of type beta transfor ...... is and dysfunction in the rat.
@en
Blockade of type beta transfor ...... is and dysfunction in the rat.
@nl
type
label
Blockade of type beta transfor ...... is and dysfunction in the rat.
@en
Blockade of type beta transfor ...... is and dysfunction in the rat.
@nl
prefLabel
Blockade of type beta transfor ...... is and dysfunction in the rat.
@en
Blockade of type beta transfor ...... is and dysfunction in the rat.
@nl
P2093
P2860
P356
P1476
Blockade of type beta transfor ...... is and dysfunction in the rat.
@en
P2093
P2860
P304
P356
10.1073/PNAS.96.5.2345
P407
P577
1999-03-01T00:00:00Z